Vimarsana
Biggest News Aggregation in the World

Page 6 - Dose Regimen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dose Regimen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dose Regimen Today - Breaking & Trending Today

MSNBC Deadline White House November 29, 2021 21:06:00 - Vimarsana News

MSNBC Deadline White House November 29, 2021 21:06:00

Here, not at run on the hospitals amongst those who have gotten fully vaccinated. also really helpful here. with all of that said, where are we now? to your paint, it is going the take some time. for all the viewers a key point for moving toward for 2022, 2023, and onwards, in the going to be the last variant. i say this as a pulmono psychiatrist, if the goal here is anything other than to keep you out of the hospital, the goal of vaccination is to prevent infection or a positive test, we are going to be constantly chasing our tail, nicolle. for flu -- as an example, for flu, every year we say...

MSNBC Andrea Mitchell Reports October 15, 2021 16:07:00 - Vimarsana News

MSNBC Andrea Mitchell Reports October 15, 2021 16:07:00

To be as cut and dry as it was with pfizer and moderna. and part of the reason is because of the data with johnson & johnson. with the mrna vaccines, we found out that you get a big bump in protection, but that protection starts wearing off over time especially that 6 to 8 month period. with johnson & johnson, it doesn't gets a high a protection, but that level stays fairly even throughout. so they are talking about if the protection is high enough, do we actually need a booster. and if it is not high enough, should they look at giving a two dose johnson & johnson instead of a booster. and the...

KPIX CBS Evening News With Norah ODonnell September 22, 2021 01:39:00 - Vimarsana News

KPIX CBS Evening News With Norah ODonnell September 22, 2021 01:39:00

Big news -- a second dose of its vaccine is 94% protective against symptomatic covid in the u.s.. nearly 15 million americans already have received this single dose regimen. tonight's other headline affects a treatment for people with covid called monoclonal antibodies, synthetic antibodies that reduce death or hospitalization by at least 70% in high-risk patients. >> it's essentially boosting your own antibodies and immune system. >> reporter: the problem is, not enough supply-- especially in states like tennessee with low vaccination rates. barely half of eligible people here have been fully...

MSNBC Craig Melvin Reports September 22, 2021 15:06:00 - Vimarsana News

MSNBC Craig Melvin Reports September 22, 2021 15:06:00

Infrastructure or lack frof in countries like rwanda and lie beer d -- liberia. you need infrastructure when it comes to the pfizer vaccines. it's a two dose regimen. you need special syringes. is the infrastructure there to support it? >> yes, so we've known for a long time the requirements for some of the vaccines. and the countries have been aware of those requirements and are taking great strides to provide some of the infrastructure including the ultra cold temperature freezers and working on the distribution networks. so it's really less so about the capacity to manage the doses but it's...

CNN At This Hour With Kate Bolduan September 7, 2021 15:22:00 - Vimarsana News

CNN At This Hour With Kate Bolduan September 7, 2021 15:22:00

Vaccines for boosters and that answer is probably yes. with you don't have data on that yet. we're expecting some data to come out in the next two to three weeks. but the fact of the matter is that answer is probably yes. and we want to hear more data absolutely on this johnson & johnson vaccine as welcome. a single dose had a 72% efficacy against symptomatic infection which is actually more potent than a single dose of moderna or pfizer. and so that is one of the reasons that they went forward with a single dose regimen as opposed to a two-dose regimen. what we would like to see is that data ...